Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential

Xie, Jennifer Y.Chew, Lindsey A.Yang, XiaofangWang, YuyingQu, ChaolingWang, YueFederici, Lauren M.Fitz, Stephanie D.Ripsch, Matthew S.Due, Michael R.Moutal, AubinKhanna, MayWhite, Fletcher A.Vanderah, Todd W.Johnson, Philip L.Porreca, FrankKhanna, Rajesh2018-03-072018-03-072016-09Xie, J. Y., Chew, L. A., Yang, X., Wang, Y., Qu, C., Wang, Y., … Khanna, R. (2016). Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential. Pain, 157(9), 2124–2140. https://doi.org/10.1097/j.pain.00000000000006280304-3959https://hdl.handle.net/1805/15409en-USPublisher PolicyCRMP2CaV2.2constellation pharmacologyneuropathic painallodyniadopamine releasenucleus accumbensconditioned place preferenceSustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potentialArticle